Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulation

Article In Press

1
0

Authors:

Di Song, M.D., Xian-liang Huang, M.D., Ling Hong, M.D., Jian-min Yu, M.D., Zhao-feng Zhang, M.D., Hui-qin Zhang, M.D., Zhao-gui Sun, Ph.D., Jing Du, Ph.D.

Abstract:

Objective

To examine whether sequence variants within the FSHR and CYP19A1 genes are related to the ovarian response to controlled ovarian stimulation (COS).

Design

Genetic association study using both single-gene and combined analyses of women with sequence variants undergoing in vitro fertilization treatment.

Setting

Academic research institute hospital.

Patient(s)

Seven hundred and five women undergoing ovarian stimulation with recombinant follicle-stimulating hormone (FSH).

Intervention(s)

Peripheral blood extraction, DNA purification, and FSHR c.919G>A (rs6165, p.Thr307Ala) and CYP19A1c.*19C>T (rs10046) sequence variants analyses.

Main Outcome Measure(s)

Single-gene statistical analysis and combined statistical analysis with the SPSS17.0 software; FSHR c.919G>A and CYP19A1 c.*19C>T sequence variant genotypes and clinical parameters related to the COS response as oocyte retrieval and hormone levels, doses of exogenous FSH.

Result(s)

Women with genotype Ala/Ala at FSHR position 307 had higher basal levels of FSH and were more likely to have a low ovarian response compared with other genotypes. Women with genotype TT at CYP19A1 yielded fewer oocytes after ovarian stimulation. The combined analysis of these two sequence variants revealed that these two single-nucleotide variants have a synergistic effect in conferring the risk of a low ovarian response.

Conclusion(s)

Our results support an association of sequence variants in the genes that participate in estrogen synthesis, notably the FSHR and CYP19A1 genes, with the outcome of COS.


Read the full text here.

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.